Expand FEMY Menu
FEMY MENU

FEMY Latest Press Releases

-- May 13, 2026 --

Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG Catheter Globe Newswire 9:00 AM

-- May 8, 2026 --

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update Globe Newswire 4:05 PM

-- May 5, 2026 --

Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed Complete Globe Newswire 9:00 AM

-- April 22, 2026 --

Femasys Launches FemaSeed Complete for OB/GYNs at ACOG 2026 Globe Newswire 9:00 AM

-- April 16, 2026 --

Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio Globe Newswire 9:00 AM

-- April 1, 2026 --

Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth Globe Newswire 9:00 AM

-- March 31, 2026 --

Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update Globe Newswire 4:05 PM

-- March 18, 2026 --

Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors Globe Newswire 9:00 AM

-- March 10, 2026 --

Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment Globe Newswire 9:00 AM

-- February 27, 2026 --

Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:26 PM

-- February 26, 2026 --

Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access Globe Newswire 9:00 AM

-- February 23, 2026 --

Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination Globe Newswire 9:00 AM

-- February 3, 2026 --

Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products Globe Newswire 9:15 AM
Market Data Delayed 15 Minutes